Presentation Details:
This talk by Brian Wood addresses the following topics:
Dual ART:
Dolutegravir/lamivudine initial ART: updated 96-week results
Islatravir + doravirine metabolic outcomes at 48 weeks
HIV Cure:
Sustained HIV remission in the London Patient
Presentation Transcript: